Table 4.
Timeliness of vaccine doses administered to surveyed children and missed opportunities by dose among surveyed children with documented vaccination histories, Timor Leste, 2016.
Vaccine dose | Timeliness1 | MOV by dose | |||||
---|---|---|---|---|---|---|---|
Total number of children who received dose2 | Too early | Timely | Late | Eligible doses due | Eligible doses missed at visit | ||
% | % | % | n | n | % | ||
Birth dose | |||||||
BCG3 | 269 | - | 88 | 12 | 31 | 6 | 19 |
OPV4 | 237 | - | 89 | 11 | 48 | 31 | 65 |
First dose | |||||||
OPV4 | 216 | 7 | 79 | 14 | 41 | 9 | 22 |
Pentavalent5 vaccine | 213 | 8 | 77 | 16 | 54 | 14 | 26 |
Second dose | |||||||
OPV4 | 163 | 7 | 71 | 22 | 29 | 3 | 10 |
Pentavalent5 vaccine | 159 | 8 | 70 | 23 | 31 | 7 | 23 |
Third dose | |||||||
OPV4 | 121 | 4 | 64 | 32 | 35 | 7 | 20 |
Pentavalent5 vaccine | 118 | 4 | 65 | 31 | 43 | 10 | 23 |
MR16 | 40 | 5 | 90 | 5 | 41 | 21 | 51 |
Total | 353 | 108 | 31 |
Please see Table 1 for intervals and immunization schedule used for this analysis.
Children with documented history of receiving a dose either on the day of survey or previously.
bacille Calmette-Guerin (BCG) vaccine.
Oral poliovirus vaccine (OPV).
Diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b (pentavalent) vaccine.
First dose of measles and rubella vaccine (MR1).